Asymmetric Unit(hide GO term definitions)
Chain A,E ( Q4A1U8_HCMV | Q4A1U8)
| biological process |
|---|
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| cellular component |
|---|
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
Chain A,E ( UL18_HCMVA | P08560)
| molecular function |
|---|
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| biological process |
|---|
| | GO:0002474 | | antigen processing and presentation of peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
| | GO:0039671 | | evasion by virus of host natural killer cell activity | | Any process by which a virus avoids the effects mediated by the host organism's natural killer (NK) cells. |
| | GO:0030683 | | evasion or tolerance by virus of host immune response | | Any process, either active or passive, by which a virus avoids the effects of the host organism's immune response. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0032689 | | negative regulation of interferon-gamma production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| | GO:0031623 | | receptor internalization | | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| cellular component |
|---|
| | GO:0033644 | | host cell membrane | | Double layer of lipid molecules as it encloses host cells, and, in eukaryotes, many organelles; may be a single or double lipid bilayer; also includes associated proteins. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
Chain B,F ( B2MG_HUMAN | P61769)
| molecular function |
|---|
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| biological process |
|---|
| | GO:0033077 | | T cell differentiation in thymus | | The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus. |
| | GO:0019731 | | antibacterial humoral response | | An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster. |
| | GO:0019885 | | antigen processing and presentation of endogenous peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class I protein complex. The peptide antigen is typically, but not always, processed from a whole protein. Class I here refers to classical class I molecules. |
| | GO:0002479 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
| | GO:0002480 | | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
| | GO:0002481 | | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | | The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class Ib protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class Ib molecule. Class Ib here refers to non-classical class I molecules, such as those of the HLA-E gene family. |
| | GO:0002474 | | antigen processing and presentation of peptide antigen via MHC class I | | The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
| | GO:0044267 | | cellular protein metabolic process | | The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
| | GO:0071281 | | cellular response to iron ion | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. |
| | GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| | GO:0050829 | | defense response to Gram-negative bacterium | | Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
| | GO:0050830 | | defense response to Gram-positive bacterium | | Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism. |
| | GO:0006955 | | immune response | | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| | GO:0060333 | | interferon-gamma-mediated signaling pathway | | A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
| | GO:0055072 | | iron ion homeostasis | | Any process involved in the maintenance of an internal steady state of iron ions within an organism or cell. |
| | GO:0010977 | | negative regulation of neuron projection development | | Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| | GO:1900121 | | negative regulation of receptor binding | | Any process that stops, prevents or reduces the frequency, rate or extent of a protein or other molecule binding to a receptor. |
| | GO:0002726 | | positive regulation of T cell cytokine production | | Any process that activates or increases the frequency, rate, or extent of T cell cytokine production. |
| | GO:0001916 | | positive regulation of T cell mediated cytotoxicity | | Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity. |
| | GO:1904434 | | positive regulation of ferrous iron binding | | Any process that activates or increases the frequency, rate or extent of ferrous iron binding. |
| | GO:0032092 | | positive regulation of protein binding | | Any process that activates or increases the frequency, rate or extent of protein binding. |
| | GO:1900122 | | positive regulation of receptor binding | | Any process that activates or increases the frequency, rate or extent of a protein or other molecule binding to a receptor. |
| | GO:0048260 | | positive regulation of receptor-mediated endocytosis | | Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
| | GO:1904437 | | positive regulation of transferrin receptor binding | | Any process that activates or increases the frequency, rate or extent of transferrin receptor binding. |
| | GO:0042026 | | protein refolding | | The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones. |
| | GO:0050690 | | regulation of defense response to virus by virus | | Any viral process that modulates the frequency, rate, or extent of the antiviral response of the host cell or organism. |
| | GO:0050776 | | regulation of immune response | | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| | GO:0003254 | | regulation of membrane depolarization | | Any process that modulates the rate, frequency or extent of membrane depolarization. Membrane depolarization is the process in which membrane potential changes in the depolarizing direction from the resting potential, usually from negative to positive. |
| | GO:0046686 | | response to cadmium ion | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus. |
| | GO:0042493 | | response to drug | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease. |
| | GO:0002237 | | response to molecule of bacterial origin | | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin. |
| | GO:0001895 | | retina homeostasis | | A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. |
| cellular component |
|---|
| | GO:0012507 | | ER to Golgi transport vesicle membrane | | The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
| | GO:0005794 | | Golgi apparatus | | A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions. |
| | GO:0000139 | | Golgi membrane | | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
| | GO:1990712 | | HFE-transferrin receptor complex | | A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription. |
| | GO:0042612 | | MHC class I protein complex | | A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0031905 | | early endosome lumen | | The volume enclosed by the membrane of an early endosome. |
| | GO:0031901 | | early endosome membrane | | The lipid bilayer surrounding an early endosome. |
| | GO:0005788 | | endoplasmic reticulum lumen | | The volume enclosed by the membranes of the endoplasmic reticulum. |
| | GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0030670 | | phagocytic vesicle membrane | | The lipid bilayer surrounding a phagocytic vesicle. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
Chain C,G ( ACTB_HUMAN | P60709)
| molecular function |
|---|
| | GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| | GO:0000978 | | RNA polymerase II core promoter proximal region sequence-specific DNA binding | | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II. |
| | GO:0000980 | | RNA polymerase II distal enhancer sequence-specific DNA binding | | Interacting selectively and non-covalently with a RNA polymerase II (Pol II) distal enhancer. In mammalian cells, enhancers are distal sequences that increase the utilization of some promoters, and can function in either orientation and in any location (upstream or downstream) relative to the core promoter. |
| | GO:0030957 | | Tat protein binding | | Interacting selectively and non-covalently with Tat, a viral transactivating regulatory protein from the human immunodeficiency virus, or the equivalent protein from another virus. |
| | GO:0042802 | | identical protein binding | | Interacting selectively and non-covalently with an identical protein or proteins. |
| | GO:0019894 | | kinesin binding | | Interacting selectively and non-covalently and stoichiometrically with kinesin, a member of a superfamily of microtubule-based motor proteins that perform force-generating tasks such as organelle transport and chromosome segregation. |
| | GO:0050998 | | nitric-oxide synthase binding | | Interacting selectively and non-covalently with the enzyme nitric-oxide synthase. |
| | GO:0031492 | | nucleosomal DNA binding | | Interacting selectively and non-covalently with the DNA portion of a nucleosome. |
| | GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0005200 | | structural constituent of cytoskeleton | | The action of a molecule that contributes to the structural integrity of a cytoskeletal structure. |
| biological process |
|---|
| | GO:0043044 | | ATP-dependent chromatin remodeling | | Dynamic structural changes to eukaryotic chromatin that require energy from the hydrolysis of ATP, ranging from local changes necessary for transcriptional regulation to global changes necessary for chromosome segregation, mediated by ATP-dependent chromatin-remodelling factors. |
| | GO:0038096 | | Fc-gamma receptor signaling pathway involved in phagocytosis | | An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes. |
| | GO:0034329 | | cell junction assembly | | A cellular process that results in the aggregation, arrangement and bonding together of a set of components to form a cell junction. |
| | GO:0048013 | | ephrin receptor signaling pathway | | The series of molecular signals generated as a consequence of an ephrin receptor binding to an ephrin. |
| | GO:0006928 | | movement of cell or subcellular component | | The directed, self-propelled movement of a cell or subcellular component without the involvement of an external agent such as a transporter or a pore. |
| | GO:0070527 | | platelet aggregation | | The adhesion of one platelet to one or more other platelets via adhesion molecules. |
| | GO:0045815 | | positive regulation of gene expression, epigenetic | | Any epigenetic process that activates or increases the rate of gene expression. |
| | GO:0001895 | | retina homeostasis | | A tissue homeostatic process involved in the maintenance of an internal equilibrium within the retina of the eye, including control of cellular proliferation and death and control of metabolic function. |
| | GO:0021762 | | substantia nigra development | | The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis). |
| | GO:0048010 | | vascular endothelial growth factor receptor signaling pathway | | Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| cellular component |
|---|
| | GO:0070688 | | MLL5-L complex | | A protein complex that can methylate lysine-4 of histone H3 and plays an essential role in retinoic-acid-induced granulopoiesis. MLL5 is the catalytic methyltransferase subunit, and the complex also contains serine/threonine kinase 38 (STK38), protein phosphatase 1 catalytic subunits, the host cell factor-1 N-terminal subunit, beta-actin, and O-GlcNAc transferase; the human genes encoding the subunits are MLL5, STK38, PPP1CA, PPP1CB, PPP1CC, HCFC1, ACTB and OGT, respectively. |
| | GO:0035267 | | NuA4 histone acetyltransferase complex | | A complex having histone acetylase activity on chromatin, as well as ATPase, DNA helicase and structural DNA binding activities. The complex is thought to be involved in double-strand DNA break repair. Subunits of the human complex include HTATIP/TIP60, TRRAP, RUVBL1, BUVBL2, beta-actin and BAF53/ACTL6A. In yeast, the complex has 13 subunits, including the catalytic subunit Esa1 (homologous to human Tip60). |
| | GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0036464 | | cytoplasmic ribonucleoprotein granule | | A ribonucleoprotein granule located in the cytoplasm. |
| | GO:0005856 | | cytoskeleton | | Any of the various filamentous elements that form the internal framework of cells, and typically remain after treatment of the cells with mild detergent to remove membrane constituents and soluble components of the cytoplasm. The term embraces intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0097433 | | dense body | | An electron dense body which may contain granules. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005925 | | focal adhesion | | Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. |
| | GO:0030529 | | intracellular ribonucleoprotein complex | | An intracellular macromolecular complex containing both protein and RNA molecules. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0000790 | | nuclear chromatin | | The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome in the nucleus. |
| | GO:0005654 | | nucleoplasm | | That part of the nuclear content other than the chromosomes or the nucleolus. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
Chain D,H ( LIRB1_HUMAN | Q8NHL6)
| molecular function |
|---|
| | GO:0030107 | | HLA-A specific inhibitory MHC class I receptor activity | | Combining with a MHC class I molecule of the HLA-A subclass to mediate signaling that inhibits activation of a lymphocyte. |
| | GO:0030109 | | HLA-B specific inhibitory MHC class I receptor activity | | Combining with a MHC class I molecule of the HLA-B subclass to mediate signaling that inhibits activation of a lymphocyte. |
| | GO:0042288 | | MHC class I protein binding | | Interacting selectively and non-covalently with major histocompatibility complex class I molecules; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation. |
| | GO:0032393 | | MHC class I receptor activity | | Combining with an MHC class I protein complex to initiate a change in cellular activity. Class I here refers to classical class I molecules. |
| | GO:0042169 | | SH2 domain binding | | Interacting selectively and non-covalently with a SH2 domain (Src homology 2) of a protein, a protein domain of about 100 amino-acid residues and belonging to the alpha + beta domain class. |
| | GO:0042803 | | protein homodimerization activity | | Interacting selectively and non-covalently with an identical protein to form a homodimer. |
| | GO:0008157 | | protein phosphatase 1 binding | | Interacting selectively and non-covalently with the enzyme protein phosphatase 1. |
| biological process |
|---|
| | GO:0002774 | | Fc receptor mediated inhibitory signaling pathway | | A series of molecular signals generated as a consequence of the binding of the Fc portion of an immunoglobulin by an Fc receptor capable of inhibiting an immune effector process contributing to an immune response. The Fc portion of an immunoglobulin is its C-terminal constant region. |
| | GO:0002309 | | T cell proliferation involved in immune response | | The expansion of a T cell population by cell division as part of an immune response. |
| | GO:0002250 | | adaptive immune response | | An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
| | GO:0071222 | | cellular response to lipopolysaccharide | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| | GO:0051607 | | defense response to virus | | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
| | GO:0097028 | | dendritic cell differentiation | | The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. |
| | GO:0002767 | | immune response-inhibiting cell surface receptor signaling pathway | | A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0032609 | | interferon-gamma production | | The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon. |
| | GO:0072643 | | interferon-gamma secretion | | The regulated release of interferon-gamma from a cell. |
| | GO:2001186 | | negative regulation of CD8-positive, alpha-beta T cell activation | | Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation. |
| | GO:2001189 | | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | | Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. |
| | GO:0001915 | | negative regulation of T cell mediated cytotoxicity | | Any process that stops, prevents, or reduces the rate of T cell mediated cytotoxicity. |
| | GO:0042130 | | negative regulation of T cell proliferation | | Any process that stops, prevents or reduces the rate or extent of T cell proliferation. |
| | GO:0046636 | | negative regulation of alpha-beta T cell activation | | Any process that stops, prevents, or reduces the frequency, rate or extent of alpha-beta T cell activation. |
| | GO:0051926 | | negative regulation of calcium ion transport | | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:0045786 | | negative regulation of cell cycle | | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| | GO:0002740 | | negative regulation of cytokine secretion involved in immune response | | Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response. |
| | GO:2000669 | | negative regulation of dendritic cell apoptotic process | | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell apoptotic process. |
| | GO:2001199 | | negative regulation of dendritic cell differentiation | | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation. |
| | GO:0045806 | | negative regulation of endocytosis | | Any process that stops, prevents, or reduces the frequency, rate or extent of endocytosis. |
| | GO:0035548 | | negative regulation of interferon-beta secretion | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta secretion. |
| | GO:0045077 | | negative regulation of interferon-gamma biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma. |
| | GO:0032689 | | negative regulation of interferon-gamma production | | Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon. |
| | GO:2001180 | | negative regulation of interleukin-10 secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-10 secretion. |
| | GO:2001183 | | negative regulation of interleukin-12 secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion. |
| | GO:0032945 | | negative regulation of mononuclear cell proliferation | | Any process that stops, prevents, or reduces the frequency, rate or extent of mononuclear cell proliferation. |
| | GO:0045953 | | negative regulation of natural killer cell mediated cytotoxicity | | Any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity. |
| | GO:2001205 | | negative regulation of osteoclast development | | Any process that stops, prevents or reduces the frequency, rate or extent of osteoclast development. |
| | GO:0014063 | | negative regulation of serotonin secretion | | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of serotonin. |
| | GO:2001202 | | negative regulation of transforming growth factor-beta secretion | | Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion. |
| | GO:0042536 | | negative regulation of tumor necrosis factor biosynthetic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis. |
| | GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| | GO:0045919 | | positive regulation of cytolysis | | Any process that activates or increases the frequency, rate or extent of cytolysis. |
| | GO:0002230 | | positive regulation of defense response to virus by host | | Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication. |
| | GO:2001193 | | positive regulation of gamma-delta T cell activation involved in immune response | | Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response. |
| | GO:0010628 | | positive regulation of gene expression | | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
| | GO:0045944 | | positive regulation of transcription from RNA polymerase II promoter | | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| | GO:0031623 | | receptor internalization | | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. |
| | GO:0050776 | | regulation of immune response | | Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
| | GO:0009615 | | response to virus | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
| | GO:0007165 | | signal transduction | | The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0009897 | | external side of plasma membrane | | The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0016021 | | integral component of membrane | | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
|
Description
